Director/PDMR Shareholding

Director/ PDMR Shareholding

Synergy Health plc

("Synergy", the "Company", or the "Group" )

Wednesday 18 July 2012

The Company announces the following transactions by certain directors and persons discharging managerial responsibilities ("PDMR"), in Synergy Health plc ordinary shares of 0.625 pence each ("Ordinary Shares") and the consequent allocations of Ordinary Shares to the LTIP Co-Invest scheme.

1) Dr Richard Steeves, Group Chief Executive Officer, has today allocated 48,658 Ordinary Shares to the LTIP Co-Invest scheme.

2) Mr Gavin Hill, Group Finance Director, has today allocated 6,100 Ordinary Shares to the LTIP Co-Invest scheme.

3) Mr Tim Mason, Group Company Secretary, purchased 2,700 Ordinary Shares at a price of 930.50 pence on 11 July 2012 and allocated these shares to the LTIP Co-Invest scheme. Following the transaction Mr Mason has an interest in 6,600 Ordinary Shares, representing 0.01% of the Company's issued share capital.

4) Mr Niclas Olsson, CEO Asia and Africa, purchased 10,000 Ordinary Shares at an average price of 923.96 pence on 16 July 2012 and allocated these shares to the LTIP Co-Invest scheme. Following the transaction Mr Olsson has an interest in 10,000 Ordinary Shares, representing 0.02% of the Company's issued share capital.

5) Dr Adrian Coward, CEO UK and Ireland, has today exercised options over 2,339 Ordinary Shares under the Company's Executive Share Option Scheme and also exercised options over 1,077 Ordinary Shares under the Company's LTIP scheme. These Ordinary Shares have been retained by Dr Coward and allocated to the LTIP Co-Invest Scheme. Following the transaction Dr Coward has an interest in 23,995 Ordinary Shares, representing 0.04% of the Company's issued share capital.

6) Mr Marcello Smit, CEO Europe and the Middle East, has today exercised options over 14,000 Ordinary Shares under the Company's LTIP scheme, and subsequently sold 9,500 Ordinary Shares at a price of 900.00 pence per share. The remaining 4,500 Ordinary Shares have been retained and allocated to the Company's LTIP Co-Invest Scheme. Following the transaction Mr Smit has an interest in 40,488 Ordinary Shares representing 0.07% of the Company's issued share capital.

7) Mr Paul Santing, Group Commercial Director, has today exercised options over 30,000 Ordinary Shares under the Company's LTIP scheme and subsequently sold 16,750 Ordinary Shares at a price of 900.00p per share. Of the remaining 13,250 Ordinary Shares retained, 7,773 Ordinary Shares have been allocated to the Company's Co-Invest Scheme. Following the transaction Mr Santing has an interest in 26,550 Ordinary Shares representing 0.05 % of the Company's issued share capital.

As a result of the above allocations to the Company's Co-Invest Scheme, the following grants been duly made;

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.